The Phase II randomized controlled clinical study to evaluate pharmacodynamics of micro-formulation over conventional eyedroppers.

Trial Profile

The Phase II randomized controlled clinical study to evaluate pharmacodynamics of micro-formulation over conventional eyedroppers.

Completed
Phase of Trial: Phase II

Latest Information Update: 20 Dec 2016

At a glance

  • Drugs Phenylephrine/tropicamide (Primary)
  • Indications Mydriasis
  • Focus Pharmacodynamics
  • Most Recent Events

    • 20 Dec 2016 Positive results published in an Eyenovia media release.
    • 06 Dec 2016 New trial record
    • 28 Nov 2016 According to Eyenovia media release, results were published in the peer-review journal Therapeutic Delivery.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top